DK1566173T3 - Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf

Info

Publication number
DK1566173T3
DK1566173T3 DK04003906T DK04003906T DK1566173T3 DK 1566173 T3 DK1566173 T3 DK 1566173T3 DK 04003906 T DK04003906 T DK 04003906T DK 04003906 T DK04003906 T DK 04003906T DK 1566173 T3 DK1566173 T3 DK 1566173T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
preparation
oral use
composition
bet
Prior art date
Application number
DK04003906T
Other languages
Danish (da)
English (en)
Inventor
Claudia Dr Mattern
Wilfried Pieper
Original Assignee
Mattern Udo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mattern Udo filed Critical Mattern Udo
Application granted granted Critical
Publication of DK1566173T3 publication Critical patent/DK1566173T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK04003906T 2004-02-20 2004-02-20 Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf DK1566173T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (de) 2004-02-20 2004-02-20 Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
DK1566173T3 true DK1566173T3 (da) 2006-12-27

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04003906T DK1566173T3 (da) 2004-02-20 2004-02-20 Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf

Country Status (16)

Country Link
US (1) US7767228B2 (de)
EP (2) EP1566173B1 (de)
JP (1) JP4800225B2 (de)
AT (1) ATE336230T1 (de)
AU (1) AU2005215108B2 (de)
BR (1) BRPI0507848A (de)
CA (1) CA2554640C (de)
DE (1) DE602004001969T2 (de)
DK (1) DK1566173T3 (de)
ES (1) ES2271714T3 (de)
NO (1) NO20064240L (de)
PT (1) PT1566173E (de)
RU (1) RU2342936C2 (de)
SI (1) SI1566173T1 (de)
WO (1) WO2005079759A2 (de)
ZA (1) ZA200606554B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1883396B1 (de) * 2005-05-18 2013-07-03 DA Volterra Abgabe von adsorbentien im colon
US8048413B2 (en) * 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
CN102238940B (zh) * 2008-12-05 2014-07-30 拜耳知识产权有限责任公司 含针状活性物质的挤出物
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
EP4208157A1 (de) 2020-09-04 2023-07-12 Elanco Us Inc. Wohlschmeckende formulierungen
CN117881425A (zh) * 2021-08-31 2024-04-12 株式会社东洋技术研究所 水栖动物用经口给药药剂
WO2023032048A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
NL294490A (de) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
AU7706598A (en) * 1997-05-30 1998-12-30 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
AU2003262643A1 (en) * 2002-08-13 2004-02-25 Intervet International B.V. Compositions and process for delivering an additive
AU2003280670A1 (en) * 2002-10-31 2004-05-25 Matsushita Electric Industrial Co., Ltd. Porous electrode and electrochemical device using the same

Also Published As

Publication number Publication date
AU2005215108B2 (en) 2010-10-07
DE602004001969D1 (de) 2006-09-28
RU2006133543A (ru) 2008-04-10
CA2554640C (en) 2011-04-12
US20050186272A1 (en) 2005-08-25
ZA200606554B (en) 2008-05-28
NO20064240L (no) 2006-11-20
SI1566173T1 (sl) 2006-12-31
EP1715850A2 (de) 2006-11-02
CA2554640A1 (en) 2005-09-01
ES2271714T3 (es) 2007-04-16
US7767228B2 (en) 2010-08-03
ATE336230T1 (de) 2006-09-15
EP1566173A1 (de) 2005-08-24
WO2005079759A2 (en) 2005-09-01
EP1566173B1 (de) 2006-08-16
PT1566173E (pt) 2006-12-29
JP2007523108A (ja) 2007-08-16
AU2005215108A1 (en) 2005-09-01
BRPI0507848A (pt) 2007-07-10
RU2342936C2 (ru) 2009-01-10
DE602004001969T2 (de) 2007-03-15
WO2005079759A3 (en) 2006-06-15
JP4800225B2 (ja) 2011-10-26

Similar Documents

Publication Publication Date Title
NO20064240L (no) Farmasoytiske forbindelser for oral administrasjon og fremgangsmate for fremstilling derav
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
DK1959992T3 (da) Immunogen sammensætning indeholdende en adjuvans.
NO20090328L (no) Nye forbindelser 385
NO20074086L (no) Fremgangsmate for fremstilling av lansoprazol
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
ATE337793T1 (de) Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
NO20052010D0 (no) Immunogen sammensetning
NO20043367L (no) Oralt farmasoytisk preparat
NO20050088L (no) Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav
TW200626553A (en) Novel compounds
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
NO20054787D0 (no) Indenderivater som farmasotiske midler
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
EA200701687A1 (ru) Гидрохлорид аморфного лерканидипина
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
CY1107028T1 (el) Παραγωγα ινδανυλ-πιπεραζινων μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
CO5690567A2 (es) Formulaciones de tableta de liberacion extendida de venlafaxina
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
WO2008039894A3 (en) Atorvastatin pharmaceutical compositions
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.